<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Receipt of Notice That a Patent Infringement Complaint Was Filed Against a Biosimilar or Interchangeable Biosimilar Applicant</h1>
    <p class="timestamp">Published: 2023-03-07 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is publishing notice that an applicant for a biologics license application (BLA) for a biosimilar or interchangeable biosimilar product submitted under the Public Health Service Act (PHS Act) (a "subsection (k) applicant") notified FDA that an action for patent infringement was filed in connection with the applicant's BLA. Under the PHS Act, within 30 days after the subsection (k) applicant is served with a complaint in an action for patent infringement des...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-04583</p>
    <p><strong>Publication Date:</strong> 2023-03-07</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/03/07/2023-04583/receipt-of-notice-that-a-patent-infringement-complaint-was-filed-against-a-biosimilar-or">https://www.federalregister.gov/documents/2023/03/07/2023-04583/receipt-of-notice-that-a-patent-infringement-complaint-was-filed-against-a-biosimilar-or</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-04583</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
